Evidence map›Paper›PMID 30026184›Full record

ArticleBlood2018

Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding.

Tine Wyseure, Esther J Cooke, Paul J Declerck, Niels Behrendt, Joost C M Meijers, Annette von Drygalski, Laurent O Mosnier

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Chemical Adjustment of Fibrinolysis.Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Hemophilic arthropathy: Current knowledge and future perspectives.Journal of thrombosis and haemostasis : JTH · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress.Research and practice in thrombosis and haemostasis · 2020
    Article
  13. Article
  14. Review
  15. Cardiac Myosin Promotes Thrombin Generation and Coagulation In Vitro and In Vivo.Arteriosclerosis, thrombosis, and vascular biology · 2020
    Article
  16. Role of thrombomodulin expression on hematopoietic stem cells.Journal of thrombosis and haemostasis : JTH · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Tine WyseureDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA.ORCID 0000-0003-2337-3443
Esther J CookeDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA.
Paul J DeclerckDepartment of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven, Belgium.
Niels BehrendtThe Finsen Laboratory, Rigshospitalet/Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Joost C M MeijersDepartment of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands; and.
Annette von DrygalskiDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA.
Laurent O MosnierDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA.ORCID 0000-0003-1195-964X
Scripps Research Institute · USAmsterdam UMC Location University of Amsterdam · NLKU Leuven · BEUniversity of Copenhagen · DK

Funding

Regulation of Protein C PathwaysR01HL142975 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI GRIFFIN, JOHN H, MOSNIER, LAURENT OLIVIER · 2018 to 2025
$7.3M
Structure-function of cytoprotective coagulation proteases and their receptorsR01HL104165 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI MOSNIER, LAURENT OLIVIER · 2011 to 2024
$6.1M
Discovery of novel vascular therapies targeting PfEMP1-mediated cytoadhesion in severe malariaR01HL130678 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI LAVSTSEN, THOMAS, MOSNIER, LAURENT OLIVIER · 2015 to 2018
$2.0M
NHLBI NIH HHS R01 HL104165NHLBI NIH HHS R01 HL130678NHLBI NIH HHS R01 HL142975
6 · The paper itself

Abstract

Joint bleeds are common in congenital hemophilia but rare in acquired hemophilia A (aHA) for reasons unknown. To identify key mechanisms responsible for joint-specific bleeding in congenital hemophilia, bleeding phenotypes after joint injury and tail transection were compared in aHA wild-type (WT) mice (receiving an anti-factor VIII [FVIII] antibody) and congenital HA (FVIII

Indexed as

AnimalsCarboxypeptidase B2Disease Models, AnimalGene DeletionHemarthrosisHemophilia AMiceMice, Inbred BALB CMice, Inbred C57BLUrokinase-Type Plasminogen ActivatorCarboxypeptidase B2Urokinase-Type Plasminogen Activator

Identifiers

PMID30026184
PMCPMC6182268
OpenAlexW2884367888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.